BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
Fernndez-Checa, Liver Unit, Hospital Clnic, Centre Esther Koplowitz, Institut dInvestigacions Biomdiques August Pi i Sunyer (IDIBAPS)Centro de Investigacin Biomdica en Red de Enfermedades Hepticas y Digestivas (CIBERehd), Planta Cuarta, C/Rossell 149, Barcelona 08036, Spain e-mail: [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a Section of the journal Frontiers in Pharmacology
(2020) Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
Start with small steps, lean on God, drink your water, and trust the process
The importance of sample preparation and storage in glutathione analysis
Frequent Nosebleeds: Regular nosebleeds without apparent cause